Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum]

Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum]

Gomari H, Forouzandeh Moghadam M, Soleimani M, Ghavami M, Khodashenas S. Int J Nanomedicine. 2019;14:5679–5690.The authors of this paper have advised that by their mistake, they omitted an important note from the Acknowledgments section on page 5688.Read the original article

Guardado en:
Detalles Bibliográficos
Autores principales: Gomari H, Forouzandeh Moghadam M, Soleimani M, Ghavami M, Khodashenas S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/089b3c9254d64f899ca5adba19a3ed48
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:089b3c9254d64f899ca5adba19a3ed48
record_format dspace
spelling oai:doaj.org-article:089b3c9254d64f899ca5adba19a3ed482021-12-02T06:41:46ZTargeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum]1178-2013https://doaj.org/article/089b3c9254d64f899ca5adba19a3ed482019-09-01T00:00:00Zhttps://www.dovepress.com/corrigendum-targeted-delivery-of-doxorubicin-to-her2-positive--peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Gomari H, Forouzandeh Moghadam M, Soleimani M, Ghavami M, Khodashenas S. Int J Nanomedicine. 2019;14:5679–5690.The authors of this paper have advised that by their mistake, they omitted an important note from the Acknowledgments section on page 5688.Read the original articleGomari HForouzandeh Moghadam MSoleimani MGhavami MKhodashenas SDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 7919-7920 (2019)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Gomari H
Forouzandeh Moghadam M
Soleimani M
Ghavami M
Khodashenas S
Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum]
description Gomari H, Forouzandeh Moghadam M, Soleimani M, Ghavami M, Khodashenas S. Int J Nanomedicine. 2019;14:5679–5690.The authors of this paper have advised that by their mistake, they omitted an important note from the Acknowledgments section on page 5688.Read the original article
format article
author Gomari H
Forouzandeh Moghadam M
Soleimani M
Ghavami M
Khodashenas S
author_facet Gomari H
Forouzandeh Moghadam M
Soleimani M
Ghavami M
Khodashenas S
author_sort Gomari H
title Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum]
title_short Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum]
title_full Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum]
title_fullStr Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum]
title_full_unstemmed Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum]
title_sort targeted delivery of doxorubicin to her2 positive tumor models [corrigendum]
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/089b3c9254d64f899ca5adba19a3ed48
work_keys_str_mv AT gomarih targeteddeliveryofdoxorubicintoher2positivetumormodelscorrigendum
AT forouzandehmoghadamm targeteddeliveryofdoxorubicintoher2positivetumormodelscorrigendum
AT soleimanim targeteddeliveryofdoxorubicintoher2positivetumormodelscorrigendum
AT ghavamim targeteddeliveryofdoxorubicintoher2positivetumormodelscorrigendum
AT khodashenass targeteddeliveryofdoxorubicintoher2positivetumormodelscorrigendum
_version_ 1718399734880665600

Ejemplares similares